
Ubilon2.5 mg
Incepta Pharmaceuticals Ltd.
Tibolone is a synthetic steroid compound with tissue-selective estrogenic, progestogenic, and weak androgenic activity, used exclusively in postmenopausal women.
Tibolone is a synthetic steroid compound with tissue-selective estrogenic, progestogenic, and weak androgenic activity, used exclusively in postmenopausal women. Its evidence-based indications are:
Tibolone is not recommended as a first-line treatment for osteoporosis prevention alone; it should be considered only when alternative therapies are unsuitable, given its safety profile (see Precautions and Warnings).
Tibolone is used only in postmenopausal women and has no role in premenopausal women, men, or children.
| Indication | Dose |
|---|---|
| Menopausal symptoms | 2.5 mg (one tablet) orally, once daily |
| Osteoporosis prevention (when other options are unsuitable) | 2.5 mg (one tablet) orally, once daily |
Tibolone should be used at the lowest effective dose for the shortest duration consistent with treatment goals, with periodic medical reassessment (see Duration of Treatment).
Possible side effects of Tibolone include:
Tibolone is also associated with a serious increased risk of ischaemic stroke, venous thromboembolism (DVT/PE), and breast cancer recurrence (see Precautions and Warnings and Contraindications for full details); these are not routine "side effects" but important safety risks that should be discussed with your physician before and during treatment.
Tibolone is contraindicated in the following situations (true absolute contraindications):
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.